Cargando…
Mutant TP53 driving the Warburg Effect in Mantle Cell lymphoma
The p53 mutation R273H in tumor cells leads to increased glucose uptake, lactic acidosis, and accelerated tumor growth, as was previously shown in mice. We here present a patient with mantle cell lymphoma harboring this p53_R273H mutation, whose clinical course is characterized by severe lactic acid...
Autores principales: | Kliebhan, Johannes, Besse, Andrej, Kampa‐Schittenhelm, Kerstin, Schittenhelm, Marcus, Driessen, Christoph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9529752/ https://www.ncbi.nlm.nih.gov/pubmed/36225622 http://dx.doi.org/10.1002/ccr3.6296 |
Ejemplares similares
-
Alternative splicing of Apoptosis Stimulating Protein of TP53-2 (ASPP2) results in an oncogenic isoform promoting migration and therapy resistance in soft tissue sarcoma (STS)
por: Tsintari, Vasileia, et al.
Publicado: (2022) -
Dasatinib overrides the differentiation blockage in a patient with mutant-KIT D816V positive CBFβ-MYH11 leukemia
por: Kampa-Schittenhelm, Kerstin M., et al.
Publicado: (2018) -
Quizartinib (AC220) is a potent second generation class III tyrosine kinase inhibitor that displays a distinct inhibition profile against mutant-FLT3, -PDGFRA and -KIT isoforms
por: Kampa-Schittenhelm, Kerstin Maria, et al.
Publicado: (2013) -
Crenolanib is a type I tyrosine kinase inhibitor that inhibits mutant KIT D816 isoforms prevalent in systemic mastocytosis and core binding factor leukemia
por: Kampa-Schittenhelm, Kerstin Maria, et al.
Publicado: (2017) -
Tumor-Associated Mutant p53 Drives the Warburg Effect
por: Zhang, Cen, et al.
Publicado: (2013)